Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: Health-related quality of life from the randomized phase 3 KEYNOTE-716 study
Resource Type
Article
Authors
Khattak, Muhammad A. ; Luke, Jason J. ; Long, Georgina V. ; Ascierto, Paolo A. ; Rutkowski, Piotr ; Schadendorf, Dirk ; Robert, Caroline ; Grob, Jean-Jacques ; de la Cruz Merino, Luis ; Del Vecchio, Michele ; Spagnolo, Francesco ; Mackiewicz, Jacek ; Chiarion-Sileni, Vanna ; Carlino, Matteo S. ; Mohr, Peter ; De Galitiis, Federica ; Ross, Merrick I. ; Eroglu, Zeynep ; Chen, Ke ; Jiang, Ruixuan ; Fukunaga-Kalabis, Mizuho ; Krepler, Clemens ; Eggermont, Alexander M.M. ; Kirkwood, John M.
Source
In European Journal of Cancer November 2022 176:207-217
Subject
Language
ISSN
0959-8049